Lymphomatoid papulosis with a natural killer-cell phenotype

Br J Dermatol. 2001 Aug;145(2):318-22. doi: 10.1046/j.1365-2133.2001.04324.x.

Abstract

Lymphomatoid papulosis (LyP) is defined as a recurrent self-healing papulonodular eruption with the histological features of a (CD30+) cutaneous T-cell lymphoma. The atypical cells usually have a CD3+/-, CD4+/-, CD8-, CD30+, CD56- T-cell phenotype. We report an unusual case of LyP, in which the atypical cells expressed a CD3-, CD4-, CD8-, CD30+, CD56+ phenotype. Detailed phenotypic and genotypic analysis confirmed that these cells had a natural killer (NK)-cell phenotype. Lymphomas with an NK-cell phenotype usually have a poor prognosis. However, the waxing and waning of papular lesions for more than 20 years and the excellent response to low-dose oral methotrexate in this patient suggest similar clinical behaviour to LyP cases with a T-cell phenotype.

Publication types

  • Case Reports
  • Review

MeSH terms

  • CD56 Antigen / genetics
  • Dermatologic Agents / therapeutic use
  • Genotype
  • Humans
  • Ki-1 Antigen / genetics
  • Killer Cells, Natural / immunology*
  • Lymphomatoid Papulosis / drug therapy
  • Lymphomatoid Papulosis / immunology*
  • Male
  • Methotrexate / therapeutic use
  • Middle Aged
  • Phenotype
  • Prognosis
  • Treatment Outcome

Substances

  • CD56 Antigen
  • Dermatologic Agents
  • Ki-1 Antigen
  • Methotrexate